PEAR Therapeutics logo

PEAR Therapeutics

A biotechnology and software company offering prescription digital therapeutics.

5

Funding Rounds

$214.0m

Money raised

Overview

A biotechnology and software company offering prescription digital therapeutics.

Funding series

Funding Series Analysis

The company PEAR Therapeutics has raised a total of $64m in funding over 5 rounds.

Key Insights:

  • PEAR Therapeutics Series C round, January 2019: $64m
  • PEAR Therapeutics Series D round December 2020: $80m
  • PEAR Therapeutics Series A round, February 2016: $20m
  • PEAR Therapeutics funding round, January 2018: $50m
PEAR Therapeutics logo
PEAR Therapeutics Series C round, January 2019 $64m
PEAR Therapeutics logo
PEAR Therapeutics Series D round December 2020 $80m
PEAR Therapeutics logo
PEAR Therapeutics Series A round, February 2016 $20m
PEAR Therapeutics logo
PEAR Therapeutics funding round, January 2018 $50m

Industries

PEAR Therapeutics is active in the following industries:
  • Technology
  • Mental health
  • Sleep aid
  • Sleep
  • Mobile game
  • Health information technology
  • Digital therapeutics
  • Therapeutics
  • Biotechnology
  • Biology
  • Entertainment
  • Digital health
  • Big data
  • Healthcare